Increased prefrontal and hippocampal glutamate concentration in schizophrenia: Evidence from a magnetic resonance spectroscopy study

Biological Psychiatry

Volumn 58, Issue 9, 2005, Pages 724-730

  Tebartz Van Elst, Ludger ^a   Valerius, Gabi ^a   Büchert, Martin ^a   Thiel, Thorsten ^a   Rüsch, Nicholas ^a   Bubl, Emanuel ^a   Hennig, Jürgen ^a   Ebert, Dieter ^a   Olbrich, Hans M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Glutamate; Glutamine; Hippocampus; MR spectroscopy; Prefrontal cortex; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; GLUTAMIC ACID; GLUTAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; AMINO ACID BRAIN LEVEL; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FACTORIAL ANALYSIS; FEMALE; HIPPOCAMPUS; HOSPITALIZATION; HUMAN; LIMBIC CORTEX; MALE; MENTAL FUNCTION; METABOLITE; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; CHRONIC DISEASE; ELECTROENCEPHALOGRAPHY; FEMALE; GLUTAMIC ACID; GLUTAMINE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYNAPSES;

EID: 27544447486     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.04.041     Document Type: Article

References (52)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed 1994 American Psychiatric Assocation Washington, DC DSM-IV
2. N.C. Andreasen Scale for the Assessment of Negative Symptoms (SANS) 1983 University of Iowa Iowa City, IA
3. R. Bartha, P.C. Williamson, D.J. Drost, A. Malla, T.J. Carr, L. Cortese Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy Arch Gen Psychiatry 54 1997 959 965
4. A. Carlsson, L.O. Hansson, N. Waters, M.L. Carlsson A glutamatergic deficiency model of schizophrenia Br J Psychiatry Suppl 37 1999 2 6
5. F. Cendes, F. Leproux, D. Melanson, R. Ethier, A. Evans, T. Peters MRI of amygdala and hippocampus in temporal lobe epilepsy J Comput Assist Tomogr 17 1993 206 210
6. B.D. Cohen, G. Rosenbaum, E.D. Luby, J.S. Gottlieb Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential thinking Arch Gen Psychiatry 6 1962 395 401
7. J.T. Coyle, G. Tsai The NMDA receptor glycine modulatory site A therapeutic target for improving cognition and reducing negative symptoms in schizophrenia Psychopharmacology (Berl) 174 1 2004 32 38
8. J.T. Coyle, G. Tsai, D. Goff Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia Ann N Y Acad Sci 1003 2003 318 327
9. J. Endicott, R.L. Spitzer, J.L. Fleiss, J. Cohen The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance Arch Gen Psychiatry 33 1976 766 771
10. T. Ernst Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations J Magn Reson 192 1993 9 19
11. T. Ernst Improved water suppression for localized in vivo 1H spectroscopy J Magn Reson 106 1995 181 186
12. N.B. Farber The NMDA receptor hypofunction model of psychosis Ann N Y Acad Sci 1003 2003 119 130
13. N.B. Farber, S.H. Kim, K. Dikranian, X.P. Jiang, C. Heinkel Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity Mol Psychiatry 7 2002 32 43
14. N.B. Farber, J.W. Newcomer, J.W. Olney The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease Prog Brain Res 116 1998 421 437
15. N.B. Farber, M.T. Price, J. Labruyere, J. Nemnich, H. St Peter, D.F. Wozniak Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity Biol Psychiatry 34 1993 119 121
16. N.B. Farber, D.F. Wozniak, M.T. Price, J. Labruyere, J. Huss, H. St Peter Age-specific neurotoxicity in the rat associated with NMDA receptor blockade Potential relevance to schizophrenia? Biol Psychiatry 38 1995 788 796
17. C. Flores, J.T. Coyle Regulation of glutamate carboxypeptidase II function in corticolimbic regions of rat brain by phencyclidine, haloperidol, and clozapine Neuropsychopharmacology 28 2003 1227 1234
18. R. Freedman Schizophrenia N Engl J Med 349 2003 1738 1749
19. D.C. Goff, J.T. Coyle The emerging role of glutamate in the pathophysiology and treatment of schizophrenia Am J Psychiatry 158 2001 1367 1377
20. V. Harms Biomathematik, Statistik und Dokumentation 1992 Harms Verlag Kiel, Germany
21. P.J. Harrison The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 122 1999 593 624
22. P.J. Harrison The hippocampus in schizophrenia A review of the neuropathological evidence and its pathophysiological implications Psychopharmacology (Berl) 174 2004 151 162
23. P.J. Harrison, A.J. Law, S.L. Eastwood Glutamate receptors and transporters in the hippocampus in schizophrenia Ann N Y Acad Sci 1003 2003 94 101
24. P.J. Harrison, D.R. Weinberger Schizophrenia genes, gene expression, and neuropathology On the matter of their convergence Mol Psychiatry 10 2005 40 68
25. S. Heckers Neuropathology of schizophrenia Cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systems Schizophr Bull 23 1997 403 421
26. S. Heckers, D. Stone, J. Walsh, J. Shick, P. Koul, F.M. Benes Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia Arch Gen Psychiatry 59 2002 521 529
27. B. Hesslinger, T. Thiel, L. Tebartz van Elst, J. Hennig, D. Ebert Attention-deficit disorder in adults with or without hyperactivity: Where is the difference? A study in humans using short echo (1)H-magnetic resonance spectroscopy Neurosci Lett 304 2001 117 119
28. D.C. Javitt, S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1991 1301 1308
29. J.S. Kim, H.H. Kornhuber, W. Schmid-Burgk, B. Holzmuller Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia Neurosci Lett 20 1980 379 382
30. C. Konradi, S. Heckers Antipsychotic drugs and neuroplasticity Insights into the treatment and neurobiology of schizophrenia Biol Psychiatry 50 2001 729 742
31. C. Konradi, S. Heckers Molecular aspects of glutamate dysregulation Implications for schizophrenia and its treatment Pharmacol Ther 97 2003 153 179
32. M. Laruelle, L.S. Kegeles, A. Abi-Dargham Glutamate, dopamine, and schizophrenia From pathophysiology to treatment Ann N Y Acad Sci 1003 2003 138 158
33. L. Lemieux, R.S.N. Liu, J.S. Duncan Hippocampal and cerebellar volumetry in serially acquired MRI volume scans Magn Reson Imaging 18 2000 1027 1033
34. E.J. Novotny Jr, R.K. Fulbright, P.L. Pearl, K.M. Gibson, D.L. Rothman Magnetic resonance spectroscopy of neurotransmitters in human brain Ann Neurol 54 suppl 6 2003 S25 S31
35. J.W. Olney, N.B. Farber Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 52 1995 998 1007
36. J.W. Olney, J. Labruyere, M.T. Price Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs Science 244 1989 1360 1362
37. J.E. Overall, D.R. Gorham The Brief Psychiatric Rating Scale Psychol Rep 10 1962 799 812
38. T.L. Perry Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction Neurosci Lett 28 1982 81 85
39. A. Phillips, N. Garmezy Phillips scale of premorbid adjustment in schizophrenia, Farina and Garmezy modification W. Guy ECDEU Assessment Manual for Psychopharmacology 1976 National Institute of Health Rockville, MD 564 567
40. S.W. Provencher Estimation of metabolite concentration from localised in vivo proton NMR spectra Magn Reson Imaging 30 1993 672 679
41. D.L. Rothman, N.R. Sibson, F. Hyder, J. Shen, K.L. Behar, R.G. Shulman In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics Philos Trans R Soc Lond B Biol Sci 354 1999 1165 1177
42. S.R. Sesack, D.B. Carr, N. Omelchenko, A. Pinto Anatomical substrates for glutamate-dopamine interactions Evidence for specificity of connections and extrasynaptic actions Ann N Y Acad Sci 1003 2003 36 52
43. D.L. Streiner, G.R. Norman From Health Measurements Scales. A Practical Guide to Their Development and Use 1995 Oxford Medical Publications London
44. L. Tebartz van Elst, D. Baeumer, L. Lemieux, F. Woermann, M.J. Koepp, E. Krishnamoorthy Amygdala abnormalities in psychosis of epilepsy. A magnetic resonance imaging study in patients with temporal lobe epilepsy Brain 125 2002 140 149
45. L. Tebartz van Elst, B. Hesslinger, T. Thiel, E. Geiger, K. Haegele, L. Lemieux Frontolimbic brain abnormalities in patients with borderline personality disorder A volumetric magnetic resonance imaging study Biol Psychiatry 54 2003 163 171
46. L. Tebartz van Elst, T. Thiel, B. Hesslinger, K. Lieb, M. Bohus, J. Hennig Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder J Neuropsychiatry Clin Neurosci 13 2001 511 514
47. L. Tebartz van Elst, F. Woermann, L. Lemieux, P.J. Thompson, M.R. Trimble Affective aggression in patients with temporal lobe epilepsy-a quantitative magnetic resonance study of the amygdala Brain 123 2000 234 243
48. L. Tebartz van Elst, F. Woermann, L. Lemieux, M.R. Trimble Amygdala enlargement in dysthymia-a volumetric study of patients with temporal lobe epilepsy Biol Psychiatry 46 1999 1614 1623
49. J. Theberge, Y. Al Semaan, P.C. Williamson, R.S. Menon, R.W. Neufeld, N. Rajakumar Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS Am J Psychiatry 160 2003 2231 2233
50. J. Theberge, R. Bartha, D.J. Drost, R.S. Menon, A. Malla, J. Takhar Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers Am J Psychiatry 159 2002 1944 1946
51. K. Ugurbil, M. Garwood, J. Ellermann, K. Hendrich, R. Hinke, X. Hu Imaging at high magnetic fields Initial experiences at 4 T Magn Reson Q 9 1993 259 277
52. A.P. Weiss, I. Dewitt, D. Goff, T. Ditman, S. Heckers Anterior and posterior hippocampal volumes in schizophrenia Schizophr Res 73 2005 103 112